Gerresheimer AG : Worst of destocking behind us – strong growth to come into perspective
>Primary Packaging Glass - Destocking to come to an end after Q2 - Destocking at glass vials started in Q3 2023 and has had a stronger impact than previously assumed. While the company described the overall underlying growth in Primary Packaging Glass as solid, we regard the quarterly decline of 13.7% in Q1 as the result of the strongest headwind from destocking from a phasing perspective. Our new FY 2024 forecast of 4% (previously 5%) organic growth for Primary Packa...Gerresheimer is a holding company. Through its subsidiaries, Co. manufactures glass and plastic products for the pharma and healthcare industry. Co.'s operates in three divisions: Plastics & Devices, which its product portfolio includes products for the administration of medicines, such as insulin pens, inhalers, and prefillable syringes; Primary Packaging Glass, which produces glass primary packaging for medicines and cosmetics, such as pharma jars, ampoules, injection vials, cartridges, perfume flacons, and cream jars; and Life Science Research, which produces laboratory glassware for research, development, and analytics, such as beakers, Erlenmeyer flasks, and measuring cylinders.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.